National Cancer Survivor Month is about more than awareness. It’s a celebration for those who have survived and an inspiration for those recently diagnosed. At Blue Note Therapeutics, we understand that every survivorship experience is unique. Our patient advisors work closely with us to support our mission. As we celebrate them, we are also honored to be part of their cancer journeys and to share what terms like “survivor” mean in their own words.
In May, Blue Note Therapeutics was joined by clinical experts from MSKCC Dr. Allison J. Applebaum, Dr. William S. Breitbart, Dr. Wendy Lichtenthal, and Dr. Hayley Pessin, along with our patient advisors Anne Marie Mercurio and Michael Mancini to discuss the origins and treatments of cancer-related distress.
During Oncology Nursing Month, Blue Note Therapeutics had the opportunity to discuss cancer-related distress with Dr. Lisa Kennedy Sheldon, oncology nurse practitioner, cancer care advocate, and former CCO for the Oncology Nursing Society.
Nearly all patients living with cancer experience some form of cancer-related distress. Yet, less than half are referred to mental health specialists. Learn how one patient is inspiring Blue Note as he advocates for cancer awareness and mental health support.
In March of 2021, Mark Elfers of Blue Note Therapeutics was joined by medical oncologists Dr. Patricia Ganz, MD (UCLA Jonsson Comprehensive Cancer Center) and Dr. Areej El-Jawahri, MD (Massachusetts General Hospital), and psycho-oncology expert Dr. Michael Antoni, PhD (Sylvester Cancer Center) to discuss advances in the field of psycho-oncology.
How one executive's nontraditional career path led to a new point of view on compassion and empathy.
Blue Note Therapeutics was founded with a commitment to involving patients in every step of its work to develop online mental health treatments for cancer-related distress. But what does that mean, exactly?